Published: June 03, 2026, 17:16 UTC
The Body’s Broken Clock: How Circadian Disruption May Drive Depression — and Why Timing-Based Treatments Are the Next Frontier
More than 300 million people worldwide live with major depressive disorder, a condition the World Health Organization estimates affects 5.7% of adults globally. For decades, treatment has revolved around talk therapy and antidepressants — serotonin reuptake inhibitors that take weeks to work and fail for roughly one in three patients. But a growing body of evidence points to a deeper mechanism underlying the disorder: the body’s internal clock itself.
A comprehensive review published today in Annals of Medicine by researchers at Zhejiang University synthesizes this evidence, arguing that circadian disruption may be causal in major depressive disorder rather than merely a symptom of it. The review, which examines genetic, neurobiological, and clinical data across hundreds of studies, opens the door to a class of treatments — chronotherapies — that target the timing systems of the brain directly.
What They Found
The review documents three converging lines of evidence linking circadian biology to depression.
Genetic links. Patients with major depressive disorder carry variants in core clock genes — particularly CLOCK, TIMELESS, and CRY1 — that correlate with both circadian misalignment and depression susceptibility. This builds on foundational work by Soria and colleagues, who showed in 2010 that CRY1 and NPAS2 variants are specifically associated with unipolar major depression, while CLOCK and VIP variants track with bipolar disorder. The Zhejiang review extends these findings, showing that disrupted clock gene expression is not merely a consequence of poor sleep but may represent an independent risk factor for developing depression.
Circadian alterations. Patients with MDD exhibit profound disruptions across multiple circadian-regulated processes: sleep-wake cycles are fragmented, diurnal mood patterns are flattened, and metabolic rhythms — including cortisol secretion and body temperature — lose their normal 24-hour periodicity. A 2020 review in Translational Psychiatry by Walker and colleagues noted that these disruptions are so consistent that sleep disturbance is already a formal diagnostic criterion for MDD, and that animal models of circadian disruption reliably produce depressive-like behaviors.
Bidirectional causality. The relationship cuts both ways. Mood disorders disrupt circadian rhythms, but circadian disruption also precipitates mood disorders. Jet lag, night-shift work, and chronic exposure to artificial light at night can trigger or worsen depressive episodes in susceptible individuals. A 2024 review in Nature Mental Health by Jorge Mendoza described how aberrant light-dark cycles alter the functioning of the suprachiasmatic nucleus — the brain’s master clock — and lead to a loss of internal synchrony among peripheral oscillators, a state the authors link directly to anxiety and depressive-like behaviors.
Why It Matters
If circadian dysregulation contributes to depression rather than simply accompanying it, then treatments that restore normal rhythmicity could address the root cause rather than downstream symptoms.
A 2025 narrative review in Current Psychiatry Reports by Swanson and colleagues examined the clinical trial evidence for four categories of chronotherapeutics: bright light therapy, dark therapy, melatonin, and sleep-wake scheduling (including sleep deprivation and timed sleep interventions). The preponderance of recent trials has focused on bright light therapy for depression, with consistent evidence that morning light exposure significantly reduces depressive symptoms. A meta-analysis published last month in Medscape covering neuropsychiatric populations found that light therapy not only reduced depression scores but also improved objective sleep quality measures.
The Zhejiang review goes further, proposing a framework for personalized chronotherapy — matching the type and timing of intervention to an individual’s circadian profile. Evening-type chronotypes (night owls), for example, may benefit more from morning light therapy combined with fixed wake times, while morning types with early-morning awakening may respond better to evening melatonin or timed blue-light avoidance. The authors also highlight emerging “chronobiotic” drugs — compounds that directly modulate clock gene expression — as a potential future treatment avenue.
Limits
The field still faces significant hurdles. The Swanson review notes that most chronotherapy trials remain small, with limited data outside of unipolar depression. Rigorous dose-finding studies for light therapy — how bright, for how long, at what time — are still lacking. The genetic association data, while robust, does not prove causation in individual patients: clock gene variants may interact with environmental triggers (shift work, seasonal light changes, social jet lag) in ways that are not yet fully mapped. And the Zhejiang review notes that many of the mechanistic findings come from animal models, whose translation to human treatment protocols remains incomplete.
Bottom Line
The recognition that circadian disruption may drive depression — rather than simply accompany it — represents a shift in how clinicians and researchers think about one of the world’s most burdensome diseases. For patients who have not responded to conventional antidepressants, chronotherapies such as structured light exposure and timed sleep scheduling offer low-risk, evidence-supported alternatives. For the field as a whole, the convergence of genetic, neurobiological, and clinical data makes a compelling case that treating the body’s clock may be as important as treating the brain’s chemistry.
Sources
1. Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers. Annals of Medicine. Zhejiang University. 2026. DOI: 10.1080/07853890.2026.2671594
2. Soria V, Martínez-Amorós E, Escaramís G, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology. 2010;35(6):1279-1289. DOI: 10.1038/npp.2009.230
3. Walker WH II, Walton JC, DeVries AC, Nelson RJ. Circadian rhythm disruption and mental health. Translational Psychiatry. 2020;10:28. DOI: 10.1038/s41398-020-0694-0
4. Mendoza J. Circadian disruptions and brain clock dysregulation in mood disorders. Nature Mental Health. 2024;2:749-763. DOI: 10.1038/s44220-024-00260-y
5. Swanson LM, Schubert JR, Raglan GB, Conroy DA. Chronotherapeutic treatments for psychiatric disorders: a narrative review of recent literature. Current Psychiatry Reports. 2025;27:161-175. DOI: 10.1007/s11920-025-01586-9
6. World Health Organization. Depressive disorder (depression). Fact sheet. Updated August 2025.